The theme of this proposal is to continue investigation into the molecular basis for regulatory events involving complex lipid reassembly nad apolipoprotein gene expression. The main focus will be studies involving lipoprotein assembly in the intestine while additional studies will extend, in certain instances, to a characterization of suitable model systems in the liver. Studies will address the molecular basis for apo B gene processing in both intestine and liver. Recent work has established that this gene undergoes a unique co- or posttranscriptional modification which results in a single base change in the mRNA, but not the gene. The proposal seeks to characterize the molecular basis and physiologic consequences of apo B mRNA modification and studies are proposed involving models of both developmentally nad hormonally regulated apo B gene expression. Other studies will address the role of cellular lipid flux in mediating the independent regulation of intestinal apolipoprotein gene expression. These studies will specifically establish whether the regulation of intestinal apo A-IV gene expression by acute triglyceride flux involves genes which coordinate the vectorial delivery of fatty acid into chylomicron triglyceride. A final group of studies will extend many of the previous observations concerning intestinal apolipoprotein biosynthesis into an investigation of hepatic apolipoprotein gene expression. Of particular interest will be the influence of alterations in enterohepatic bile salt and cholesterol flux since these manipulations have each been demonstrated to modulate intestinal apolipoprotein gene expression in a manner which is distinct for each of the apolipoprotein genes. Taken together, these studies should provide fundamental information concerning the molecular and cell biology of lipoprotein biogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038180-07
Application #
3354260
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1986-07-01
Project End
1995-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Lin, Jianguo; Zheng, Shizhong; Attie, Alan D et al. (2018) Perilipin 5 and liver fatty acid binding protein function to restore quiescence in mouse hepatic stellate cells. J Lipid Res 59:416-428
Willet, Spencer G; Lewis, Mark A; Miao, Zhi-Feng et al. (2018) Regenerative proliferation of differentiated cells by mTORC1-dependent paligenosis. EMBO J 37:
Eberth, Jan M; Josey, Michele J; Mobley, Lee R et al. (2018) Who Performs Colonoscopy? Workforce Trends Over Space and Time. J Rural Health 34:138-147
Cifarelli, Vincenza; Ivanov, Stoyan; Xie, Yan et al. (2017) CD36 deficiency impairs the small intestinal barrier and induces subclinical inflammation in mice. Cell Mol Gastroenterol Hepatol 3:82-98
Xu, Jun; Ma, Hsiao-Yen; Liang, Shuang et al. (2017) The role of human cytochrome P450 2E1 in liver inflammation and fibrosis. Hepatol Commun 1:1043-1057
Xie, Yan; Cifarelli, Vincenza; Pietka, Terri et al. (2017) Cd36 knockout mice are protected against lithogenic diet-induced gallstones. J Lipid Res 58:1692-1701
Schootman, M; Hendren, S; Loux, T et al. (2017) Differences in Effectiveness and Use of Robotic Surgery in Patients Undergoing Minimally Invasive Colectomy. J Gastrointest Surg 21:1296-1303
Wen, Yahong; Liao, Grace; Pritchard, Thomas et al. (2017) A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair. J Biol Chem 292:6148-6162
Newberry, Elizabeth P; Xie, Yan; Kennedy, Susan M et al. (2017) Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice. Hepatology 65:836-852
Lo, Hei-Yong G; Jin, Ramon U; Sibbel, Greg et al. (2017) A single transcription factor is sufficient to induce and maintain secretory cell architecture. Genes Dev 31:154-171

Showing the most recent 10 out of 163 publications